SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-20-000107
Filing Date
2020-01-10
Accepted
2020-01-10 19:41:38
Documents
2
Period of Report
2020-01-06

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1623
2 POWER OF ATTORNEY ex24-1.htm EX-24.1 5648
  Complete submission text file 0001062993-20-000107.txt   8756
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOSPECIFICS TECHNOLOGIES CORP 2 RIGHTER PARKWAY SUITE 200 WILMINGTON DE 19803
Business Address
HUTCHISON PATRICK (Reporting) CIK: 0001673870 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34236 | Film No.: 20522332